Phase 1 Study of LQT-1213 in Healthy Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
This is a single-center, randomized, double-blind, placebo-controlled study to be conducted in 2 parts: single ascending dose (SAD) incorporating a food effect arm and multiple ascending dose (MAD). Potential participants for each part will undergo screening procedures within 28 days of enrollment.
Epistemonikos ID: 145215e7ec07f2c3edbb1b2806d99b9531468523
First added on: Feb 19, 2024